Sarah Starling Crossan is named as a lobbyist on federal disclosure filings for 7 clients through Holland & Knight LLP. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations and Medicare/Medicaid.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| UNITED MITOCHONDRIAL DISEASE FOUNDATION | HOLLAND & KNIGHT LLP | Q3 2026 | Health Issues, Budget/Appropriations |
| PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | HOLLAND & KNIGHT LLP | Q3 2026 | Medical/Disease Research/Clinical Labs |
| ABRIDGE AI, INC. | HOLLAND & KNIGHT LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| PROTECTING ACCESS TO PAIN RELIEF COALITION | HOLLAND & KNIGHT LLP | Q3 2026 | Health Issues |
| FPMCM, LLC D/B/A FAST PACE HEALTH | HOLLAND & KNIGHT LLP | Q4 2025 | Health Issues |
| ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS | HOLLAND & KNIGHT LLP | Q4 2025 | Health Issues |
| NATIONAL ASSOCIATION OF EMS PHYSICIANS | HOLLAND & KNIGHT LLP | Q2 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 4 | 1 |
| 2025 | 5 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Sarah Starling Crossan. See the Capitol Clarity rankings and method.